BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1389 related articles for article (PubMed ID: 10944113)

  • 21. Activation of hypoxia-induced transcription in normoxia.
    Hägg M; Wennström S
    Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
    Clifford SC; Cockman ME; Smallwood AC; Mole DR; Woodward ER; Maxwell PH; Ratcliffe PJ; Maher ER
    Hum Mol Genet; 2001 May; 10(10):1029-38. PubMed ID: 11331613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.
    Bonicalzi ME; Groulx I; de Paulsen N ; Lee S
    J Biol Chem; 2001 Jan; 276(2):1407-16. PubMed ID: 11024059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors.
    Blagosklonny MV
    Oncogene; 2001 Jan; 20(3):395-8. PubMed ID: 11313969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins.
    Srinivas V; Zhang LP; Zhu XH; Caro J
    Biochem Biophys Res Commun; 1999 Jul; 260(2):557-61. PubMed ID: 10403805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIF activation by pH-dependent nucleolar sequestration of VHL.
    Mekhail K; Gunaratnam L; Bonicalzi ME; Lee S
    Nat Cell Biol; 2004 Jul; 6(7):642-7. PubMed ID: 15181450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.
    Groulx I; Lee S
    Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
    Wykoff CC; Pugh CW; Maxwell PH; Harris AL; Ratcliffe PJ
    Oncogene; 2000 Dec; 19(54):6297-305. PubMed ID: 11175344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.
    Isaacs JS; Jung YJ; Mimnaugh EG; Martinez A; Cuttitta F; Neckers LM
    J Biol Chem; 2002 Aug; 277(33):29936-44. PubMed ID: 12052835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress.
    Salnikow K; Donald SP; Bruick RK; Zhitkovich A; Phang JM; Kasprzak KS
    J Biol Chem; 2004 Sep; 279(39):40337-44. PubMed ID: 15271983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
    Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
    Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer.
    Maynard MA; Ohh M
    Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.
    Huang LE; Gu J; Schau M; Bunn HF
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7987-92. PubMed ID: 9653127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The von Hippel-Lindau tumor suppressor gene.
    Kondo K; Kaelin WG
    Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene.
    Hughson MD; He Z; Liu S; Coleman J; Shingleton WB
    Cancer Genet Cytogenet; 2003 Jun; 143(2):145-53. PubMed ID: 12781449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway.
    Kallio PJ; Wilson WJ; O'Brien S; Makino Y; Poellinger L
    J Biol Chem; 1999 Mar; 274(10):6519-25. PubMed ID: 10037745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
    Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
    J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transduction. How do cells sense oxygen?
    Zhu H; Bunn HF
    Science; 2001 Apr; 292(5516):449-51. PubMed ID: 11292863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding and regulation of HIF-1alpha by a subunit of the proteasome complex, PSMA7.
    Cho S; Choi YJ; Kim JM; Jeong ST; Kim JH; Kim SH; Ryu SE
    FEBS Lett; 2001 Jun; 498(1):62-6. PubMed ID: 11389899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.